Spyre Therapeutics, Inc. Cash Flow Statement

Cash Flow Statement Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -8.90M-11.29M-21.66M-27.19M-44.29M-78.25M-80.89M-65.80M-83.81M-338.79M-208.02M
Share-based Compensation 0.84M0.81M1.22M2.49M4.28M4.88M6.26M8.04M7.11M25.68M44.83M
Gains from Sales and Divestitures 0.03M0.03M
Gains from Investment Securities 0.63M1.15M2.36M3.14M3.89M5,357.84M6.61M10.13M-0.92M
Asset Writedowns and Impairment 2.58M
Non-cash Items 2.83M0.44M2.48M1.16M1.77M3.79M3,181.98M4.09M
Cash from Operations -7.33M-10.98M-18.84M-24.61M-32.19M-65.69M-75.78M-53.72M-80.14M-99.91M-157.41M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.00M-0.10M-0.07M0.59M0.82M-0.07M-0.55M0.40M2.32M11.40M
Depreciation & Amortization (CF) 0.02M0.09M0.13M0.25M0.30M0.42M1.00M1.58M1.57M0.74M
Change in Working Capital
Change in Receivables 1.70M-0.48M1.86M-3.08M0.81M-0.44M-0.38M
Change in Account Payables -0.17M-0.17M-0.01M0.16M0.24M2.58M-0.54M1.06M-2.64M-2.40M-15.98M
Change in Accured Expenses 0.30M1.12M1.83M1.67M4.17M5.12M-1.15M-0.37M-0.84M-4.89M14.61M
Investing Activities
Capital Expenditures 0.18M0.21M0.21M0.62M0.42M1.49M4.28M0.57M0.04M
Sales of Property, Plant and Equipment 0.47M
Change in Intangibles 15.00M
Acquisitions 3.04M
Change in Acquisitions & Divestments 8.45M42.20M47.37M91.68M125.68M111.03M96.55M39.90M245.97M
Cash from Investing Activities -0.22M-4.01M-12.08M-22.53M-15.23M-1.74M-7.60M-22.62M57.01M-108.39M-353.29M
Financing Activities
Other financing activities 0.15M0.02M1.22M2.49M4.28M4.88M6.26M8.04M7.11M
Change in Capital Stock
Shares Issued 0.02M0.08M0.83M3.02M1.45M0.82M1.90M0.22M0.41M7.51M
Preferred Shares Issued 5.58M43.68M197.36M
Misc.
Cash from Financing Activities 5.58M41.67M49.37M12.21M57.07M65.72M154.51M1.39M42.68M361.08M410.91M
Exchange Rate Effect 0.05M-0.01M-0.11M0.03M-0.00M
Change in Cash -1.98M26.68M18.45M-34.93M9.64M-1.71M71.18M-74.96M19.44M152.80M-99.79M
Beginning Cash Balance 4.60M2.62M29.29M47.75M12.82M20.96M18.91M90.10M15.43M36.09M189.22M
Free Cash Flow -7.52M-11.19M-19.05M-25.23M-32.62M-67.18M-80.06M-54.29M-80.18M-99.91M-157.41M
Net Cash Flow -1.98M26.68M18.45M-34.93M9.64M-1.71M71.13M-74.94M19.54M152.77M-99.79M